1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
2. WHO. 2006. Proposal to waive in vivo bioequivalence requirements for WHO model list of essential medicines immediate-release, solid oral dosage forms. Technical Report Series No. 937, 40th Report, Annex 8 of WHO Expert committee on specifications for pharmaceutical preparations. Available from URL http://healthtech.who.int/pq/info3_general/documents/TRS937/WHO_TRS_937_annex8_eng.pdf
3. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). 2000. Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. Available from URL http://www.fda.gov/cder/guidance/3618fnl.pdf.
4. Committee for Proprietary Medicinal Products (CPMP). 2007. Concept paper on BCS-based biowaiver. Available from URL http://www.emea.europa.eu/pdfs/human/ewp/21303507en.pdf
5. Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol);Kalantzi;J Pharm Sci,2006